Dynatronics (NASDAQ:DYNT) Given Buy Rating at Maxim Group

Maxim Group reissued their buy rating on shares of Dynatronics (NASDAQ:DYNT) in a research note released on Thursday morning, AnalystRatings.com reports. Maxim Group currently has a $2.00 price target on the medical equipment provider’s stock.

Other equities research analysts also recently issued research reports about the company. Aegis reissued a market perform rating and set a $1.45 price objective on shares of Dynatronics in a report on Thursday, July 2nd. Zacks Investment Research raised Dynatronics from a strong sell rating to a hold rating in a report on Thursday, July 2nd. LADENBURG THALM/SH SH reissued a buy rating and set a $1.30 price objective on shares of Dynatronics in a report on Thursday, July 2nd. Finally, ValuEngine raised Dynatronics from a hold rating to a buy rating in a report on Friday, May 1st. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Dynatronics has a consensus rating of Buy and a consensus price target of $1.50.

Shares of DYNT traded up $0.03 during midday trading on Thursday, hitting $0.85. The company’s stock had a trading volume of 8,989 shares, compared to its average volume of 2,489,583. The company has a quick ratio of 0.56, a current ratio of 1.28 and a debt-to-equity ratio of 0.44. Dynatronics has a one year low of $0.63 and a one year high of $3.70. The stock has a market capitalization of $11.47 million, a price-to-earnings ratio of -3.46 and a beta of -0.18. The company’s fifty day simple moving average is $0.82 and its two-hundred day simple moving average is $0.93.

Dynatronics (NASDAQ:DYNT) last released its quarterly earnings data on Thursday, May 14th. The medical equipment provider reported ($0.13) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by ($0.09). Dynatronics had a negative net margin of 2.24% and a negative return on equity of 13.41%. The firm had revenue of $13.71 million for the quarter. On average, research analysts predict that Dynatronics will post -0.41 earnings per share for the current year.

An institutional investor recently raised its position in Dynatronics stock. Renaissance Technologies LLC lifted its holdings in Dynatronics Co. (NASDAQ:DYNT) by 69.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 50,100 shares of the medical equipment provider’s stock after acquiring an additional 20,600 shares during the period. Renaissance Technologies LLC owned approximately 0.57% of Dynatronics worth $42,000 as of its most recent filing with the Securities and Exchange Commission. 6.93% of the stock is currently owned by institutional investors.

Dynatronics Company Profile

Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products.

See Also: Net Margin

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.